Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 23Thoracic 2Sarcoma 1Head & Neck 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 30Small Cell Lung Carcinoma 13Recurrence 3Melanoma 3Lung Neoplasms 3Advanced Lung Cancer 3NSCLC 2Lymphoma 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Treatment-naive Advanced Non-small Cell Lung Cancer 1Thoracic Neoplasms 1Stage IB-IIIB NSCLC 1Small Cell Lung Cancer Limited Stage 1Sarcoma 1SCLC, Extensive Stage 1Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1Ovarian Neoplasms 1Non-small Lung Cancer 1Non Squamous Non Small Cell Lung Cancer 1Non Small Cell Lung Cancer Recurrent 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mesothelioma, Malignant 1Lung Diseases 1Local Advanced Non-small Cell Lung Cancer 1Liver Neoplasms 1Kidney Neoplasms 1

Interventions

pembrolizumab 24Nivolumab 19atezolizumab 9Specimen Handling 7Magnetic Resonance Spectroscopy 7Cyclophosphamide 7durvalumab 5Ipilimumab 5fludarabine 4Trastuzumab 4cemiplimab 3cabozantinib 3avelumab 3Sunitinib 3Biopsy 3ulixertinib 2toripalimab 2tislelizumab 2spartalizumab 2sargramostim 2relatlimab 2palbociclib 2lenvatinib 2epacadostat 2enzalutamide 2cyclopropapyrroloindole 2copanlisib 2budigalimab 2aldesleukin 2X-Rays 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × toripalimab × Thoracic × Clear all
NCT04374877 2025-11-10

Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

Coherus Oncology, Inc.

Phase 1 Completed
145 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Neoplasms

NCT05757492 2025-05-01

Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Coherus Oncology, Inc.

Phase 1 Terminated
22 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡